1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-620.
2. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, Yoon HI, Lim SC, Park JY, Park SJ, Seo KH, Kim KU, Oh YM, Lee NY, Kim JS, Oh KW, Kim YT, Park IW, Lee SD, Kim SK, Kim YK, Han SK. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-665.
4. Korea Academy of Tuberculosis and Respiratory Diseases. COPD clinical practice guidelines revised in 2018 [Internet] Seoul: Korean Academy of Tuberculosis and Respiratory Disease. 2018;cited 2018 Sep 1. Available from:
http://www.lungkorea.org/bbs/?code=guide
5. Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, Gouskova NA, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Lazarus SC, Martinez FJ, Paine R 3rd, Rennard S, Tashkin DP, Han MK. SPIROMICS Research Group. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 2016;374:1811-1821.
6. Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA. Influence of anxiety on health outcomes in COPD. Thorax 2010;65:229-234.
7. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008;31:492-501.
8. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000;118:656-664.
9. Chung KS, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Song JH. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population. Int J Chron Obstruct Pulmon Dis 2016;11:1957-1963.
10. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-1440.
12. Lee S, Lee JS, Song JW, Choi CM, Shim TS, Kim TB, Cho YS, Moon HB, Lee SD, Oh YM. Validation of the Korean version of chronic obstructive pulmonary disease assessment test (CAT) and dyspnea-12 questionnaire. Tuberc Respir Dis 2010;69:171-176.
13. Lee SD, Huang MS, Kang J, Lin CH, Park MJ, Oh YM, Kwon N, Jones PW, Sajkov D. Investigators of the Predictive Ability of CAT in Acute Exacerbations of COPD (PACE) Study. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med 2014;108:600-608.
14. Korea Academy of Tuberculosis and Respiratory Diseases. Resource center: CAT [Internet] Seoul: Korean Academy of Tuberculosis and Respiratory Disease. 2018;cited 2018 Sep 8. Available from:
http://www.lungkorea.org/calculator/?code=cat
15. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's respiratory questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
16. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003;41:46s-53s.
17. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
18. Kim MH, Lee K, Kim KU, Park HK, Jeon DS, Kim YS, Lee MK, Park SK. Risk factors associated with frequent hospital readmissions for exacerbation of COPD. Tuberc Respir Dis 2010;69:243-249.
20. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32:962-969.